Chiron Shareholders Approve Novartis Offer
- Share via
From the Associated Press
Biotechnology company Chiron Corp. said that its shareholders had approved an offer from Swiss drug maker Novartis to acquire all remaining shares of the company for $48 a share, or about $5.4 billion.
Chiron expects the acquisition to close today.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
